Gain Therapeutics, Inc. Common Stock (GANX)

Etorro trading 970x250

About Gain Therapeutics, Inc. Common Stock

Gain Therapeutics, Inc., a development stage biotechnology company, develops novel therapeutics to treat rare genetic and neurological disorders caused by protein misfolding in Switzerland and Spain. The company through its in-licensed proprietary Site-Directed Enzyme Enhancement Therapy platform, discovers novel allosteric sites on misfolded proteins, identifies proprietary binding sites, and restores protein folding. It has a research collaboration agreement with Sumitomo Dainippon Pharma Co., Ltd. for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. The company was founded in 2017 and is based in Bethesda, Maryland. Address: 4800 Hampden Lane, Bethesda, MD, United States, 20814

Gain Therapeutics, Inc. Common Stock News and around…

Latest news about Gain Therapeutics, Inc. Common Stock (GANX) common stock and company :

Gain Therapeutics Appoints Matthias Alder as Chief Operating Officer
19 Oct, 2021 Yahoo! Finance

BETHESDA, Md., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding sites never before targeted in neurodegenerative diseases and lysosomal storage disorders, today announced the appointment of Matthias Alder as Chief Operating Officer to advance the Company’s strategic and operational objectives, including the establishment of additional industry partnerships and the

Gain Therapeutics' SEE-Tx™ Platform Shows Increasing Evidence in Treating Diseases Caused by Protein Misfolding
12 Oct, 2021 FinancialContent

Image by National Cancer Institute on Unsplash Medical and technological advancements are extending our lifespan. Unfortunately, as ...

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Gain Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
23 Sep, 2021 FinancialContent

Conference Dates: September 27th-30th

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
21 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Gain Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
17 Sep, 2021 FinancialContent
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
15 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Gain Therapeutics to Present at 2021 International Virtual GM1 Community Conference
09 Sep, 2021 FinancialContent
54 Biggest Movers From Yesterday
09 Sep, 2021 FinancialContent

Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on ...

Why Gain Therapeutics Shares Are Trading Higher Today
08 Sep, 2021 FinancialContent

Gain Therapeutics Inc (NASDAQ: GANX) are trading higher Wednesday after the companyannounced positive topline data in a ...

30 Stocks Moving In Wednesday's Mid-Day Session
08 Sep, 2021 FinancialContent

Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New ...

Gain Therapeutics' Gaucher, Parkinson's Candidate Shows Potential In Patient-Derived iPSC Study
08 Sep, 2021 FinancialContent

The topline datafrom a study conducted at the University of Maryland School of Medicine (UMSOM) byGain Therapeutics ...

Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson’s Disease
08 Sep, 2021 Yahoo! Finance

GT-02287and GT-02329 compounds display positive effects on GCase activityand related parameters---Study results demonstrate an increase in GCase protein levels with transport to the lysosomes and decrease of glucosylceramide and α-synuclein-p129 levels---Comprehensive study results to be presented at Michael J. Fox Foundation’s upcoming Innovating from Drug Discovery to the Clinic: Novel Approaches to PD Therapeutic Development webinar---IND-initiating study planned for Q4’21 BETHESDA, Md., Sept

Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson’s Disease
08 Sep, 2021 FinancialContent
Gain Therapeutics, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
02 Sep, 2021 FinancialContent
Strong Cash Position of $43.2 Million Provides Runway into 2nd half of 2023 to Advance the Company's Programs for Gain Therapeutics, Inc. (NASDAQ: GANX)
24 Aug, 2021 FinancialContent
Strong Cash Position of $43.2 Million Provides Runway into 2nd half of 2023 to Advance the Company’s Programs for Gain Therapeutics, Inc. (NASDAQ: GANX)
23 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
17 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Stocks That Hit 52-Week Lows On Friday
13 Aug, 2021 FinancialContent

Friday morning, 94 companies reached new 52-week lows. Significant Points: Wix.com (NASDAQ:WIX) is the ...

Gain Therapeutics, Inc. Reports Second Quarter 2021 Financial Results and Business Update
11 Aug, 2021 FinancialContent
This NASDAQ is Unlocking New Treatments for Neurodegenerative and Lysosomal Storage Diseases: Gain Therapeutics, Inc. (NASDAQ: GANX)
04 Aug, 2021 FinancialContent
Gain Therapeutics to Present at the BTIG Virtual Biotechnology Conference
03 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
03 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
28 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
16 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
24 Jun, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Is Gain Therapeutics, Inc. (GANX) A Good Stock To Buy?
21 Jun, 2021 Yahoo! Finance

In this article we will analyze whether Gain Therapeutics, Inc. (NASDAQ:GANX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead […]

What Percentage Of Gain Therapeutics, Inc. (NASDAQ:GANX) Shares Do Insiders Own?
19 Jun, 2021 Yahoo! Finance

A look at the shareholders of Gain Therapeutics, Inc. ( NASDAQ:GANX ) can tell us which group is most powerful...

Gain Therapeutics, Inc. Common Stock (GANX) is a NASDAQ Common Stock listed in , ,

970x250